Dec 17 (Reuters) - ViroGates A/S VIROG.CO :
* SAID ON MONDAY IT WILL REORGANISE ITS MARKETING, SALES
DEPARTMENT TO FOCUS ON LONGEVITY AND HEALTH SEGMENT
* REVISES 2024 GUIDANCE
* NOW EXPECTS 2024 REVENUE BETWEEN DKK 4.5 AND 5 MLN
(PREVIOUSLY
DKK 4.5 AND 6 MLN)
* EXPECTS 2024 EBIT OF DKK -14.5 TO -15.5 MILLION
(PREVIOUSLY DKK
-14 AND -15.5 MLN)
* AS RESULT OF REORGANISATION, VIROGATES EXPECTS SOME
POSITIONS TO
BE MADE REDUNDANT
* WILL SET ASIDE SEVERANCE COSTS IN 2024 FINANCIAL STATEMENT
Source text for Workspace: urn:newsml:reuters.com:*:nMFN1CJmHN
Further company coverage: VIROG.CO
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))